The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J. Shah, William Oh, Michael J. Morris et al.|JNCI Cancer Spectrum|2022Cited by 11
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)David R. Wise, Kwok‐Kin Wong, Samuel R. Denmeade et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 9